These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2305456)

  • 21. Secretory IgA anti-cholera toxin antibodies in rat serum after intestinal immunization and bile duct ligation.
    Vaerman JP; Pierre P; De Ryck-Langendries A
    Adv Exp Med Biol; 1987; 216B():1661-8. PubMed ID: 3425453
    [No Abstract]   [Full Text] [Related]  

  • 22. The origin and antigen-dependent distribution of IgA-containing cells in the intestine.
    Husband AJ; Gowans JL
    J Exp Med; 1978 Nov; 148(5):1146-60. PubMed ID: 722238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal immune response to cholera toxin in ageing rats. I. Antibody and antibody-containing cell response.
    Schmucker DL; Daniels CK; Wang RK; Smith K
    Immunology; 1988 Aug; 64(4):691-5. PubMed ID: 3169843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small intestine transplantation in the rat--immunology and function.
    Kirkman RL; Lear PA; Madara JL; Tilney NL
    Surgery; 1984 Aug; 96(2):280-7. PubMed ID: 6611597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal addressin cell-adhesion molecule-1 controls plasma-cell migration and function in the small intestine of mice.
    Schippers A; Leuker C; Pabst O; Kochut A; Prochnow B; Gruber AD; Leung E; Krissansen GW; Wagner N; Müller W
    Gastroenterology; 2009 Sep; 137(3):924-33. PubMed ID: 19450594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitoxic cholera immunity in mice: influence of antigen deposition on antitoxin-containing cells and protective immunity in different parts of the intestine.
    Lange S; Nygren H; Svennerholm AM; Holmgren J
    Infect Immun; 1980 Apr; 28(1):17-23. PubMed ID: 7189747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgA antibodies in rat bile inhibit cholera toxin-induced secretion in ileal loops in situ.
    Tamaru T; Brown WR
    Immunology; 1985 Aug; 55(4):579-83. PubMed ID: 4018842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplification of the secretory IgA response to Toxoplasma gondii using cholera toxin.
    Bourguin I; Chardes T; Mevelec MN; Woodman JP; Bout D
    FEMS Microbiol Lett; 1991 Jul; 65(3):265-71. PubMed ID: 1916225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ir gene control of the murine secretory IgA response to cholera toxin.
    Elson CO; Ealding W
    Eur J Immunol; 1987 Mar; 17(3):425-8. PubMed ID: 3106062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local and systemic antibody responses and immunological memory in humans after immunization with cholera B subunit by different routes.
    Svennerholm AM; Gothefors L; Sack DA; Bardhan PK; Holmgren J
    Bull World Health Organ; 1984; 62(6):909-18. PubMed ID: 6335849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal immunity: implications for vaccine development.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies.
    Uren TK; Wijburg OL; Simmons C; Johansen FE; Brandtzaeg P; Strugnell RA
    Eur J Immunol; 2005 Jan; 35(1):180-8. PubMed ID: 15593123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of experimental trichinosis on intestinal secretion and on local antibody formation to cholera toxin.
    Ljungström I; Holmgren J; Huldt G; Lange S; Svennerholm AM
    Scand J Infect Dis Suppl; 1980; Suppl 24():79-81. PubMed ID: 6937981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against murine intestinal amoebiasis induced by oral immunization with the 29 kDa antigen of Entamoeba histolytica and cholera toxin.
    Carrero JC; Contreras-Rojas A; Sánchez-Hernández B; Petrosyan P; Bobes RJ; Ortiz-Ortiz L; Laclette JP
    Exp Parasitol; 2010 Nov; 126(3):359-65. PubMed ID: 20303954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.
    Abd Alla MD; White GL; Rogers TB; Cary ME; Carey DW; Ravdin JI
    Infect Immun; 2007 Aug; 75(8):3812-22. PubMed ID: 17526742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutralization of cholera toxin by rat bile secretory IgA antibodies.
    Vaerman JP; Derijck-Langendries A; Rits M; Delacroix D
    Immunology; 1985 Mar; 54(3):601-3. PubMed ID: 3918935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral immunization against experimental cholera: the role of antigen form and antigen combinations in evoking protection.
    Pierce NF; Cray WC; Sacci JB; Craig JP; Germanier R; Fürer E
    Ann N Y Acad Sci; 1983 Jun; 409():724-33. PubMed ID: 6603186
    [No Abstract]   [Full Text] [Related]  

  • 39. Histology of rat small bowel transplants: cyclosporine A ameliorates features of rejection including apoptosis and ganglion cell reduction.
    Collins MH; Yang R; Liu Q; Cnaan A; Pescovitz MD; Grosfeld JL
    J Pediatr Surg; 1997 Apr; 32(4):555-9. PubMed ID: 9126753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral immunization against cholera toxin with a live Yersinia enterocolitica carrier in mice.
    Van Damme M; Sory MP; Biot T; Vaerman JP; Cornelis GR
    Gastroenterology; 1992 Aug; 103(2):520-31. PubMed ID: 1634070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.